BeOne Medicines (ONC) Cash & Equivalents Growth (1y) (2016 - 2026)
BeOne Medicines (ONC) Cash & Equivalents Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | 15.53% |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 90.42% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 17.50% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -4.13% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Alnylam Pharmaceuticals | 36.08 Bn | 33.07 Bn | 959.66 Mn | 67.78% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 90.42% |
| Dec 31, 2025 | 73.08% |
| Sep 30, 2025 | 49.41% |
| Jun 30, 2025 | 6.30% |
| Mar 31, 2025 | -9.91% |
| Dec 31, 2024 | -17.16% |
| Sep 30, 2024 | -11.91% |
| Jun 30, 2024 | -23.98% |
| Mar 31, 2024 | -21.06% |
| Dec 31, 2023 | -18.03% |
| Sep 30, 2023 | 1,605,835.08% |
| Jun 30, 2023 | -24.73% |
| Mar 31, 2023 | 1,072,216.36% |
| Dec 31, 2022 | 1,179,645.12% |
| Sep 30, 2022 | -99.99% |
| Jun 30, 2022 | 1,461,557.10% |
| Mar 31, 2022 | -99.98% |
| Dec 31, 2021 | -99.98% |
| Sep 30, 2021 | 468,818.64% |
| Jun 30, 2021 | -99.98% |